Loto Biotech
Loto Biotech is a biotech startup developing a proprietary AI-driven platform to design siRNA-based pro-drugs for rare genetic disorders, with a focus on autosomal dominant diseases.
Loto Biotech has raised €600k across 1 funding round from 1 investor, most recently a round in Jun 2025. Based in L’Aquila, Italy; active in Healthtech. Data as of 28 Oct 2026.
L’Aquila, Italywww.lotobiotech.com ↗
Total raised
€600k
€600,000
Funding rounds
1
Investors
1
distinct backers
Active since
2025-06
latest 2025-06
Funding by year
EUR raised per yearLoto Biotech — funding by year — interactive chart.
Data table
| Loto Biotech — funding by year | |
|---|---|
| 2025 | €600k |
Signals
High confidenceRaise-next likelihood43
base rate 30% for Other
- ▲ In typical raise window
- ▼ Low backer re-investment
Timing: in window vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
1 round| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2025-06-30 | Other | €600k | Scientifica Venture Capital | View deal → |
Investors
1Related news
Similar companies
same sector or country- Philips€2.6BNetherlands · Healthtech
- Isomorphic Labs€2.3BUK · Healthtech
- Bending Spoons€1.7BItaly · Software
- CMR Surgical€1.5BUK · Healthtech
- Roivant Sciences€1.1BSwitzerland · Healthtech
- Neko Health€924MSweden · Healthtech
Global coverage: FundingData